NCT06145802 2026-04-29Clinical Study of Autologous Tumor Infiltrating Lymphocyte Injection (GT316) in the Treatment of Advanced Solid Tumors (Gynecological Tumors)Grit BiotechnologyPhase NA Withdrawn